Diagnostic accuracy of the Finnish Diabetes Risk Score for the prediction of undiagnosed type 2 diabetes, prediabetes, and metabolic syndrome in the Lebanese University
- PMID: 33014142
- PMCID: PMC7526372
- DOI: 10.1186/s13098-020-00590-8
Diagnostic accuracy of the Finnish Diabetes Risk Score for the prediction of undiagnosed type 2 diabetes, prediabetes, and metabolic syndrome in the Lebanese University
Abstract
Background: Risk scores were mainly proved to predict undiagnosed type 2 diabetes mellitus (UT2DM) in a non-invasive manner and to guide earlier clinical treatment. The objective of the present study was to assess the performance of the Finnish Diabetes Risk Score (FINDRISC) for detecting three outcomes: UT2DM, prediabetes, and the metabolic syndrome (MS).
Methods: This was a prospective, cross-sectional study during which employees aged between 30 and 64, with no known diabetes and working within the faculties of the Lebanese University (LU) were conveniently recruited. Participants completed the FINDRISC questionnaire and their glucose levels were examined using both fasting blood glucose (FBG) and oral glucose tolerance tests (OGTT). Furthermore, they underwent lipid profile tests with anthropometry.
Results: Of 713 subjects, 397 subjects (55.2% female; 44.8% male) completed the blood tests and thus were considered as the sample population. 7.6% had UT2DM, 22.9% prediabetes and 35.8% had MS, where men had higher prevalence than women for these 3 outcomes (P = 0.001, P = 0.003 and P = 0.001) respectively. The AUROC value with 95% Confidence Interval (CI) for detecting UT2DM was 0.795 (0.822 in men and 0.725 in women), 0.621(0.648 in men and 0.59 in women) for prediabetes and 0.710 (0.734 in men and 0.705 in women) for MS. The correspondent optimal cut-off point for UT2DM was 11.5 (sensitivity = 83.3% and specificity = 61.3%), 9.5 for prediabetes (sensitivity = 73.6% and specificity = 43.1%) and 10.5 (sensitivity = 69.7%; specificity = 56.5%) for MS.
Conclusion: The FINDRISC can be considered a simple, quick, inexpensive, and non-invasive instrument to use in a Lebanese community of working people who are unaware of their health status and who usually report being extremely busy because of their daily hectic work for the screening of UT2DM and MS. However, it poorly screens for prediabetes in this context.
Keywords: AUROC; Cutoff; FBG; FINDRISC; MS; OGTT; Prediabetes; Screening; UT2DM; WC.
© The Author(s) 2020.
Conflict of interest statement
Competing interestsThe authors declare that they have no competing interests.
Figures
Similar articles
-
Performance of the Finnish Diabetes Risk Score and a Simplified Finnish Diabetes Risk Score in a Community-Based, Cross-Sectional Programme for Screening of Undiagnosed Type 2 Diabetes Mellitus and Dysglycaemia in Madrid, Spain: The SPREDIA-2 Study.PLoS One. 2016 Jul 21;11(7):e0158489. doi: 10.1371/journal.pone.0158489. eCollection 2016. PLoS One. 2016. PMID: 27441722 Free PMC article.
-
Comparison of the Finnish Diabetes Risk Score Model With the Metabolic Syndrome in a Shanghai Population.Front Endocrinol (Lausanne). 2022 Feb 22;13:725314. doi: 10.3389/fendo.2022.725314. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35273562 Free PMC article.
-
FINDRISC modified for Cuba as a tool for the detection of prediabetes and undiagnosed diabetes in cuban population.Rev Peru Med Exp Salud Publica. 2025 Jan 31;41(4):351-364. doi: 10.17843/rpmesp.2024.414.14138. Rev Peru Med Exp Salud Publica. 2025. PMID: 39936758 Free PMC article.
-
Evaluation of Finnish Diabetes Risk Score in screening undiagnosed diabetes and prediabetes among U.S. adults by gender and race: NHANES 1999-2010.PLoS One. 2014 May 22;9(5):e97865. doi: 10.1371/journal.pone.0097865. eCollection 2014. PLoS One. 2014. PMID: 24852786 Free PMC article.
-
Evaluating FINDRISC as a screening tool for type 2 diabetes among overweight adults in the PREVIEW:NZ cohort.Prim Care Diabetes. 2017 Dec;11(6):561-569. doi: 10.1016/j.pcd.2017.07.003. Epub 2017 Aug 8. Prim Care Diabetes. 2017. PMID: 28801192 Clinical Trial.
Cited by
-
A dual domain systematic review and meta-analysis of risk tool accuracy to predict cardiovascular morbidity in prehypertension and diabetic morbidity in prediabetes.Front Endocrinol (Lausanne). 2025 Jul 22;16:1527092. doi: 10.3389/fendo.2025.1527092. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40766291 Free PMC article.
-
Prediction of Diabetes and Prediabetes among the Saudi Population Using a Non-Invasive Tool (AUSDRISK).Medicina (Kaunas). 2024 May 7;60(5):775. doi: 10.3390/medicina60050775. Medicina (Kaunas). 2024. PMID: 38792958 Free PMC article.
-
Using HbA1c measurements and the Finnish Diabetes Risk Score to identify undiagnosed individuals and those at risk of diabetes in primary care.BMC Public Health. 2023 Jan 31;23(1):211. doi: 10.1186/s12889-023-15122-y. BMC Public Health. 2023. PMID: 36721135 Free PMC article.
-
Prevalence of prediabetes and associated risk factors in the Eastern Mediterranean Region: a systematic review.BMC Public Health. 2025 Apr 12;25(1):1382. doi: 10.1186/s12889-025-22598-3. BMC Public Health. 2025. PMID: 40221721 Free PMC article.
-
Psychosis metabolic risk calculator (PsyMetRiC) in early psychosis: External validation study in Finland.Acta Psychiatr Scand. 2025 Jan;151(1):56-68. doi: 10.1111/acps.13752. Epub 2024 Aug 29. Acta Psychiatr Scand. 2025. PMID: 39209447 Free PMC article.
References
-
- Goyal R, Jialal I. Diabetes Mellitus Type 2. Treasure Island (FL): StatPearls Publishing; 2019.
-
- Centers for Disease Control and Prevention. National Diabetes Statistics Report. U.S. Dept of Health and Human Services; 2017 p. 20.
LinkOut - more resources
Full Text Sources
Miscellaneous